Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | CCR5 | P51681 | 5/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ANPEP | P15144 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24142105 | 1.00 | MAPK1 (0.43) | MAPK1TDP1ALDH1A1L3MBTL1ATM | |
| SCHEMBL28577303 | 0.90 | MMP2 (0.46) | MAPK1TDP1ALDH1A1L3MBTL1ATM | |
| SCHEMBL24142137 | 0.89 | MMP2 (0.46) | MAPK1TDP1ALDH1A1L3MBTL1ATM | |
| SCHEMBL30695875 | 0.86 | MAPK1 (0.41) | MAPK1TDP1ALDH1A1L3MBTL1ATM | |
| SCHEMBL30695869 | 0.86 | CCR5 (0.42) | MAPK1TDP1ALDH1A1L3MBTL1ATM | |
| SCHEMBL23668284 | 0.83 | MAPK1 (0.43) | MAPK1TDP1ALDH1A1L3MBTL1ATM | |
| SCHEMBL24141866 | 0.81 | MAPK1 (0.45) | MAPK1TDP1ALDH1A1L3MBTL1ATM | |
| SCHEMBL23668286 | 0.81 | MMP1 (0.43) | MAPK1TDP1ALDH1A1L3MBTL1ATM | |
| SCHEMBL23668279 | 0.79 | CCR5 (0.43) | MAPK1TDP1ALDH1A1ATMCCR5 | |
| SCHEMBL23668274 | 0.79 | MAPK1 (0.39) | MAPK1TDP1ALDH1A1L3MBTL1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210403427-A1 | METHOD FOR PRODUCING AMINO ACID DERIVATIVES | API CORPORATION (JP) | 2021-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210403427-A1 | METHOD FOR PRODUCING AMINO ACID DERIVATIVES | PTGS2, PTGES, PTGES2 | MAPK1 770/4885TDP1 3836/4885ALDH1A1 1057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.